House Panel Turns Up Heat On J&J Over Recalls

Law360, New York (June 3, 2010, 3:28 PM EDT) -- Congressional scrutiny on Johnson & Johnson Services Inc. is increasing, with a U.S. House of Representatives committee launching probes into whether the company conducted “phantom” recalls of Motrin in 2008 and its connection to a recently announced recall of PediaCare made at a J&J plant.

The House Committee on Oversight and Government Reform on Wednesday pressed the pharmaceutical giant's CEO, William C. Weldon, for details on a 2008 “phantom” recall of certain types of Motrin, which the committee first uncovered while reviewing documents turned over by...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.